Roswell Biotechnologies is a molecular electronics company transforming DNA sequencing with their latest platform, designed to deliver the disruptive performance required for future biomedical and industrial applications. The platform technology, ENDSeq™ (Electronic Nano-Device Sequencing), deploys single molecule sensor nanotechnology in a scalable semiconductor chip format, to deliver a dramatic reduction in the cost of genome-sequencing with unprecedented speed, accuracy and simplicity. Roswell is focused on delivering the molecular electronics chip and system that provides a $100, 1-hour whole human genome for use in precision medicine.